10x Genomics Reports Q4 Loss, Revenue Meets Estimates

PLEASANTON, Calif. -- 10x Genomics Inc. (TXG) announced a fourth-quarter loss of $49 million. The Pleasanton, California-based company reported a loss per share of 40 cents, missing analysts' expectations of a 32-cent loss.

Despite the loss, revenue for the quarter reached $165 million, matching Street forecasts. For the full year, 10x Genomics posted a loss of $182.6 million ($1.52 per share) on revenue of $610.8 million.